Top

American Journal of Clinical Dermatology

Published in:

01-04-2008 | Case Report

Persistent Erythema Multiforme Treated with Thalidomide

Authors: Chia-Wei Chen, Dr Tsen-Fang Tsai, Yu-Fu Chen, Chih-Ming Hung

Published in: American Journal of Clinical Dermatology | Issue 2/2008

Abstract

Erythema multiforme is a common self-limited disorder that predominantly affects younger individuals. It is characterized by typical iris or target lesions on the skin and mucous membranes. Three clinical subgroups of erythema multiforme have been identified: classical erythema multiforme, recurrent erythema multiforme, and persistent erythema multiforme. By definition, persistent erythema multiforme is characterized by the occurrence of continuous typical and atypical lesions without interruption. We report a 15-year-old boy who developed persistent erythema multiforme for 6 months and responded to treatment with thalidomide.

Fritsch PO, Ruiz-Maldonado R. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. In: Fitzpatrick TB, Eisen AZ, Wolff K, editors. Dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2003: 543–57

Drago F, Parodi A, Rebora A. Persistent erythema multiforme: report of two new cases and review of literature. J Am Acad Dermatol 1995 Aug; 33 (2Pt2): 366–9PubMedCrossRef

Duhra P, Paul CJ. Continuous erythema multiforme clearing on dapsone [letter]. Br J Dermatol 1988 May; 118 (5): 731PubMedCrossRef

Drago F, Romagnoli M, Loi A. Epstein-Barr virus-related persistent erythema multiforme in chronic fatigue syndrome. Arch Dermatol 1992 Feb; 128 (2): 217–22PubMedCrossRef

Berard F, Pincemaille B, Charhon A. Persistent erythema multiforme associated with chronic hepatitis C virus infection: efficacy of interferon alpha. Ann Dermatol Venereol (French) 1997 124 (4): 329–31

Pavlovic MD, Karadaglic DM, Kandolf LO. Persistent erythema multiforme: a report of three cases. J Eur Acad Dermatol Venereol 2001 Jan; 15 (1): 54–8PubMedCrossRef

Conejo-Mir JS, del Canto S, Munoz MA. Thalidomide as elective treatment in persistent erythema multiforme; report of two cases. J Drugs Dermatol 2003 Jan; 2 (1): 40–4PubMed

Hoffman LD, Hoffman MD. Dapsone in the treatment of persistent erythema multiforme. J Drugs Dermatol 2006 Apr; 5 (4): 375–6PubMed

Chapman RS, Forsyth A, MacQueen A. Erythema multiforme in association with active ulcerative colitis and Crohn’s disease. Dermatologica 1977 154 (1): 32–8PubMedCrossRef

10.

Davidson DM, Jegasothy BV. Atypical erythema multiforme: a marker of malignancy? Cutis 1980 Sep; 26 (3): 276–8PubMed

11.

Mahendran R, Grant JW, Norris PG. Dapsone-responsive persistent erythema multiforme. Dermatology 2000 200 (3): 281–2PubMedCrossRef

12.

Jones RR. Azathioprine therapy in the management of persistent erythema mul- tiforme. Br J Dermatol 1981 Oct; 105 (4): 465–7PubMedCrossRef

13.

Leigh IM, Mowbray JF, Levene GM. Recurrent and continuous erythema multiforme: a clinical and immunological study. Clin Exp Dermatol 1985 Jan; 10 (1): 58–67PubMedCrossRef

14.

Prussick R, Shear NH. Dapsone hypersensitivity syndrome. J Am Acad Dermatol 1996 Aug; 35 (2Pt2): 346–9PubMedCrossRef

15.

Laffitte E, Revuz J. Thalidomide. Ann Dermatol Venereol (French) 2000 Jun-Jul; 127 (6-7): 603–13

16.

Roujeau JC. Treatment of severe drug eruption. J Dermatol 1999 Nov; 26 (11): 718–22PubMed

17.

Calderon P, Anzilotti M, Phelps R. Thalidomide in dermatology: new indications for an old drug. Int J Dermatol 1997 Dec; 36 (12): 881–7PubMedCrossRef

18.

Stirling DI. Thalidomide and its impact in dermatology. Semin Cutan Med Surg 1998 Dec; 17 (4): 231–42PubMedCrossRef

19.

Faver IR, Guerra SG, Su WP. Thalidomide for dermatology: a review of clinical uses and adverse effects. Int J Dermatol 2005 Jan; 44 (1): 61–7PubMedCrossRef

20.

Ochonisky S, Verroust J, Bastuji-Garin S. Thalidomide neuropathy incidence and clinico-electrophysiologic findings in 42 patients. Arch Dermatol 1994 Jan; 130 (1): 66–9PubMedCrossRef

21.

Bastuji-Garin S, Ochonisky S, Bouche P. Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients. J Invest Dermatol 2002 Nov; 119 (5): 1020–6PubMedCrossRef

Title: Persistent Erythema Multiforme Treated with Thalidomide
Authors: Chia-Wei Chen
Dr Tsen-Fang Tsai
Yu-Fu Chen
Chih-Ming Hung
Publication date: 01-04-2008
Publisher: Springer International Publishing
Published in: American Journal of Clinical Dermatology / Issue 2/2008
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI: https://doi.org/10.2165/00128071-200809020-00006

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Persistent Erythema Multiforme Treated with Thalidomide

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2008

Safety and Efficacy of Subcutaneously Administered Efalizumab in Adults with Moderate-to-Severe Hand and Foot Psoriasis

Quality of Life and Treatment Satisfaction among Patients with Psoriasis and Psoriatic Arthritis and Patients with Psoriasis Only

Keratosis Follicularis Spinulosa Decalvans Associated with Acne Keloidalis Nuchae and Tufted Hair Folliculitis

Cutaneous Plexiform Schwannoma of the Finger Not Associated with Neurofibromatosis

Probiotics for the Treatment or Prevention of Atopic Dermatitis

Videodermatoscopy Enhances the Diagnostic Capability of Palmar and/or Plantar Psoriasis